| Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study … S Vucic, J Ryder, L Mekhael, RD Henderson, S Mathers, M Needham, ... Medicine 99 (6), e18904, 2020 | 33 | 2020 |
| Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis T Spelman, L Mekhael, T Burke, H Butzkueven, S Hodgkinson, ... European journal of neurology 23 (4), 729-736, 2016 | 24 | 2016 |
| Time-to-treatment In the management of relapsing/remitting multiple sclerosis LG Pont, M Semerdijan, T Burke, L Mekhael, S Vucic, V Hughes Pharmacoepidemiology and Drug Safety 25 (Supplement s3), 207-208, 2016 | | 2016 |
| Risk of early relapse following switch to oral agents for multiple sclerosis T Spelman, L Mekhael, T Burke, H Butzkueven, S Hodgkinson, ... MULTIPLE SCLEROSIS JOURNAL 21, 270-271, 2015 | | 2015 |
